ECZEMA, ATOPIC
Clinical trials for ECZEMA, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ECZEMA, ATOPIC trials appear
Sign up with your email to follow new studies for ECZEMA, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new medication called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 participants will receive either the drug or a placebo to see if it reduces skin redness, thickness, and itching over 24 weeks. The goal is to find a saf…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill could ease severe eczema itch and rash
Symptom relief Recruiting nowThis study tests an experimental daily tablet (PF-08049820) for adults with moderate to severe eczema (atopic dermatitis). About 165 participants will take either the study drug or a placebo for 12 weeks. Researchers will check skin improvement, itching, and safety through clinic…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a daily pill called soquelitinib in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take either the drug or a placebo for 12 weeks, and doctors track skin improvements and side effects. The goal is to see if soquelitinib can safely red…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC